Walensky Defends Decision To Go Against Advisors On Pfizer COVID Booster Recommendation
Executive Summary
‘If I had been in the room, I would have voted yes,’ CDC director says of ACIP. ‘This was a scientific close call. ... And that was how my recommendations came out after listening to all of their scientific deliberations.’
You may also be interested in...
FDA Advisory Committees Continue To Come Under Congressional Scrutiny
Rep. Anna Eshoo, the ranking Democrat on the House Energy and Commerce health subcommittee suggested FDA and CDC vaccine advisory committees contributed to the public’s confusion during the pandemic response.
With Many More COVID-19 Vaccine Changes Ahead, ACIP Expecting Fewer Public Meetings
CDC’s Advisory Committee on Immunization Practices wants a more feasible and sustainable meeting schedule in 2022, which would reduce transparency.
US CDC Panel Moves To Simplify Pfizer/BioNTech, Moderna COVID-19 Vaccine Booster Recommendations
Citing considerations of simplification, implementation and equity, Advisory Committee on Immunization Practices says everyone ages ≥50 years should get an mRNA vaccine booster dose and recommends all individuals ≥18 years have the option of getting one, without regard to occupational exposure or underlying medical conditions.